These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12867204)

  • 21. Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use.
    Nunes EV; Quitkin FM; Brady R; Stewart JW
    Am J Psychiatry; 1991 May; 148(5):667-9. PubMed ID: 2018172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of outreach case management in re-enrolling discharged methadone patients.
    Coviello DM; Zanis DA; Wesnoski SA; Alterman AI
    Drug Alcohol Depend; 2006 Oct; 85(1):56-65. PubMed ID: 16675163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.
    Afriandi I; Siregar AY; Meheus F; Hidayat T; van der Ven A; van Crevel R; Baltussen R
    Health Policy; 2010 Apr; 95(1):69-73. PubMed ID: 20004491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facilitating treatment entry among out-of-treatment injection drug users.
    Booth RE; Kwiatkowski C; Iguchi MY; Pinto F; John D
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):116-28. PubMed ID: 9722817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can heroin-dependent individuals benefit from a methadone maintenance treatment program before they drop out against medical advice? A 12-month follow-up study.
    Wang PW; Wu HC; Lin HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Eur Addict Res; 2013; 19(3):155-64. PubMed ID: 23182770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone maintenance and needle/syringe sharing.
    Longshore D; Hsieh S; Danila B; Anglin MD
    Int J Addict; 1993 Aug; 28(10):983-96. PubMed ID: 8407026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambivalence toward methadone treatment among intravenous drug users.
    Rosenblum A; Magura S; Joseph H
    J Psychoactive Drugs; 1991; 23(1):21-7. PubMed ID: 1941364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Street-level drug law enforcement and entry into methadone maintenance treatment.
    Weatherburn D; Lind B
    Addiction; 2001 Apr; 96(4):577-87. PubMed ID: 11300961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
    Verrando R; Robaeys G; Matheï C; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):81-5. PubMed ID: 15832591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment.
    Hopwood M; Southgate E; Kippax S; Bammer G; Isaac-Toua G; MacDonald M
    Aust N Z J Public Health; 2003 Oct; 27(5):551-5. PubMed ID: 14651404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.
    McNeely J; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2006 Jul; 31(1):51-7. PubMed ID: 16814010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intramuscular methadone in managing intravenous drug abuse.
    Bezant EM
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.
    Strathdee SA; Ricketts EP; Huettner S; Cornelius L; Bishai D; Havens JR; Beilenson P; Rapp C; Lloyd JJ; Latkin CA
    Drug Alcohol Depend; 2006 Jul; 83(3):225-32. PubMed ID: 16364566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.
    Hagan H; McGough JP; Thiede H; Hopkins S; Duchin J; Alexander ER
    J Subst Abuse Treat; 2000 Oct; 19(3):247-52. PubMed ID: 11027894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injecting behaviour and risky needle use amongst methadone maintenance clients.
    White JM; Dyer KR; Ali RL; Gaughwin MD; Cormack S
    Drug Alcohol Depend; 1994 Jan; 34(2):113-9. PubMed ID: 8026298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.